In 2023 KPNC began to roll out the 8-week Kaiser Permanente Accelerate for Depression (KPX-D) program to provide care to adult members with moderate-severe to severe depressive disorders in an efficient and structured track format. This study will assess the utilization and impact of KPX-D on our health system in terms of clinical outcomes, resource utilization, and relapse prevention. The results of this study will inform operational leadership of potential refinements to the program as well as other Kaiser Permanente regions.
Studying Kaiser Permanente Accelerate for Depression (KPX-D) Treatment Track Outcomes
Investigator: Kubo, Ai; Ridout, Samuel
Funder: TPMG Delivery Science Projects Program